Skip to main content

SlateStone Wealth, LLC

SEC CIK
0001764049
Latest filing
Jul 20, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by SlateStone Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q3 2022
Holdings of ALNY by SlateStone Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−1,100−100.0%Sold outHolders
Q2 20231,100$209.0K<0.1%00.0%UnchangedHolders
Q1 20231,100$220.0K<0.1%00.0%UnchangedHolders
Q4 20221,100$261.4K0.1%00.0%UnchangedHolders
Q3 20221,100$220.0K0.1%+1,100NewHolders